Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Mucin 1-mediated chemo-resistance in lung cancer cells.

Ham SY, Kwon T, Bak Y, Yu JH, Hong J, Lee SK, Yu DY, Yoon DY.

Oncogenesis. 2016 Jan 18;5:e185. doi: 10.1038/oncsis.2015.47.

2.

Muc1 enhances the β-catenin protective pathway during ischemia-reperfusion injury.

Al-Bataineh MM, Kinlough CL, Poland PA, Pastor-Soler NM, Sutton TA, Mang HE, Bastacky SI, Gendler SJ, Madsen CS, Singh S, Monga SP, Hughey RP.

Am J Physiol Renal Physiol. 2016 Mar 15;310(6):F569-79. doi: 10.1152/ajprenal.00520.2015. Epub 2016 Jan 6.

PMID:
26739894
3.

Hyper Expression of Mucin 5ac Indicates Poor Cancer Prognoses: A Meta-Analysis.

Wang X, Yan F, Shi R, Huang X, Lu S, Xu L, Ren B.

Medicine (Baltimore). 2016 Jan;95(1):e2396. doi: 10.1097/MD.0000000000002396. Review.

4.

Pseudomonas aeruginosa stimulates tyrosine phosphorylation of and TLR5 association with the MUC1 cytoplasmic tail through EGFR activation.

Kato K, Lillehoj EP, Kim KC.

Inflamm Res. 2016 Mar;65(3):225-33. doi: 10.1007/s00011-015-0908-8. Epub 2015 Dec 8.

PMID:
26645913
5.

The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic.

Gabitzsch ES, Tsang KY, Palena C, David JM, Fantini M, Kwilas A, Rice AE, Latchman Y, Hodge JW, Gulley JL, Madan RA, Heery CR, Balint JP Jr, Jones FR, Schlom J.

Oncotarget. 2015 Oct 13;6(31):31344-59. doi: 10.18632/oncotarget.5181.

6.

Binding of Galectin-3, a β-Galactoside-binding Lectin, to MUC1 Protein Enhances Phosphorylation of Extracellular Signal-regulated Kinase 1/2 (ERK1/2) and Akt, Promoting Tumor Cell Malignancy.

Mori Y, Akita K, Yashiro M, Sawada T, Hirakawa K, Murata T, Nakada H.

J Biol Chem. 2015 Oct 23;290(43):26125-40. doi: 10.1074/jbc.M115.651489. Epub 2015 Sep 4.

PMID:
26342075
7.

Mucin1 promotes the migration and invasion of hepatocellular carcinoma cells via JNK-mediated phosphorylation of Smad2 at the C-terminal and linker regions.

Wang J, Liu G, Li Q, Wang F, Xie F, Zhai R, Guo Y, Chen T, Zhang N, Ni W, Yuan H, Tai G.

Oncotarget. 2015 Aug 7;6(22):19264-78.

8.

NEU1 Sialidase Regulates Membrane-tethered Mucin (MUC1) Ectodomain Adhesiveness for Pseudomonas aeruginosa and Decoy Receptor Release.

Lillehoj EP, Hyun SW, Liu A, Guang W, Verceles AC, Luzina IG, Atamas SP, Kim KC, Goldblum SE.

J Biol Chem. 2015 Jul 24;290(30):18316-31. doi: 10.1074/jbc.M115.657114. Epub 2015 May 11.

9.

MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signaling.

Giannakouros P, Comamala M, Matte I, Rancourt C, Piché A.

Am J Cancer Res. 2014 Dec 15;5(1):219-30. eCollection 2015.

10.

The role of the small GTPase Rab31 in cancer.

Chua CE, Tang BL.

J Cell Mol Med. 2015 Jan;19(1):1-10. doi: 10.1111/jcmm.12403. Epub 2014 Dec 3. Review.

11.
12.

MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.

Mori Y, Akita K, Tanida S, Ishida A, Toda M, Inoue M, Yashiro M, Sawada T, Hirakawa K, Nakada H.

J Biol Chem. 2014 Dec 19;289(51):35193-204. doi: 10.1074/jbc.M114.586461. Epub 2014 Nov 4.

13.

Targeting the oncogenic MUC1-C protein inhibits mutant EGFR-mediated signaling and survival in non-small cell lung cancer cells.

Kharbanda A, Rajabi H, Jin C, Tchaicha J, Kikuchi E, Wong KK, Kufe D.

Clin Cancer Res. 2014 Nov 1;20(21):5423-34. doi: 10.1158/1078-0432.CCR-13-3168. Epub 2014 Sep 4.

14.

Cell Models for the Investigation of the Role of the Mucin MUC1 Extracellular Domain in Metastasizing.

Syrkina MS, Rubtsov MA, Potashnikova DM, Kondratenko YD, Dokrunova AA, Veiko VP.

Acta Naturae. 2014 Apr;6(2):62-70.

15.

MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress.

Felder M, Kapur A, Gonzalez-Bosquet J, Horibata S, Heintz J, Albrecht R, Fass L, Kaur J, Hu K, Shojaei H, Whelan RJ, Patankar MS.

Mol Cancer. 2014 May 29;13:129. doi: 10.1186/1476-4598-13-129. Review.

16.

Protein mislocalization: mechanisms, functions and clinical applications in cancer.

Wang X, Li S.

Biochim Biophys Acta. 2014 Aug;1846(1):13-25. doi: 10.1016/j.bbcan.2014.03.006. Epub 2014 Apr 4. Review.

17.

Interactions between MUC1 and p120 catenin regulate dynamic features of cell adhesion, motility, and metastasis.

Liu X, Yi C, Wen Y, Radhakrishnan P, Tremayne JR, Dao T, Johnson KR, Hollingsworth MA.

Cancer Res. 2014 Mar 1;74(5):1609-20. doi: 10.1158/0008-5472.CAN-13-2444. Epub 2013 Dec 26.

18.

MUC1-C oncoprotein promotes FLT3 receptor activation in acute myeloid leukemia cells.

Liu S, Yin L, Stroopinsky D, Rajabi H, Puissant A, Stegmaier K, Avigan D, Kharbanda S, Kufe D, Stone R.

Blood. 2014 Jan 30;123(5):734-42. doi: 10.1182/blood-2013-04-493858. Epub 2013 Nov 26.

19.

MUC1 regulates expression of multiple microRNAs involved in pancreatic tumor progression, including the miR-200c/141 cluster.

Mohr AM, Bailey JM, Lewallen ME, Liu X, Radhakrishnan P, Yu F, Tapprich W, Hollingsworth MA.

PLoS One. 2013 Oct 15;8(10):e73306. doi: 10.1371/journal.pone.0073306. eCollection 2013.

20.

Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.

Tanida S, Akita K, Ishida A, Mori Y, Toda M, Inoue M, Ohta M, Yashiro M, Sawada T, Hirakawa K, Nakada H.

J Biol Chem. 2013 Nov 1;288(44):31842-52. doi: 10.1074/jbc.M113.471318. Epub 2013 Sep 17.

Items per page

Supplemental Content

Write to the Help Desk